Axsome Therapeutics (AXSM) PT Raised to $259 at UBS
Tweet Send to a Friend
(Updated - April 10, 2026 9:31 AM EDT)
UBS analyst Ashwani Verma raised the price target on Axsome Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst Ashwani Verma raised the price target on Axsome Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
